| Literature DB >> 21169190 |
Bill D Gogas1, John T Parissis, Efstathios K Iliodromitis, Sotirios Tsiodras, Maria Radu, Ioannis A Paraskevaidis, Stergios P Theodoropoulos, Dimitrios T Kremastinos, Magdi H Yacoub.
Abstract
Infection following the implantation of a left ventricular assist device (LVAD) is a life-threatening complication with mortality rates ranging from 15% to 44%. Staphylococcus aureus and Staphylococcus epidermidis are the most frequently identified pathogens and are responsible for 60% of LVAD-related infections, local as well as systemic. In this report we describe the successful therapeutic management of a patient who received a Heart Mate II as "bridging-to-recovery", which was complicated by device infection that was managed without device explantation.Entities:
Mesh：
Year: 2010 PMID： 21169190
Source DB: PubMed Journal: Hellenic J Cardiol ISSN： 1109-9666